शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
KRSNAANSEKrsnaa Diagnostics Limited· Healthcare ServicesHighNeutral
Announced Mon, 25 May, 2026 · 20:15 IST

Krsnaa Diagnostics Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.

Profit growth above 25%Debt to equity above the thresholdEmphasis of matterNegative operating cash flowResults View source PDFExplain this filing

KRSNAA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-1.5%Reaction day
₹550.00
prior close
₹622.55
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.7%-2.2% vs market
Healthcare Service Provider peers, median of 24sector-1.3%-0.1% vs sector

On the reaction day the stock moved 2.2 pts less than Nifty Microcap 250 and 0.1 pts less than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-7.9
10m
-9.7
15m
-8.8
30m
-8.4
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-1.5+0.7-2.2-1.3-0.1
Next day
-1.8+0.7-2.5+1.3-3.1
2d
+0.0+0.0-0.0+1.2-1.2
3d
-1.7-1.1-0.6-1.3-0.4
4d
-0.5+0.0-0.5-1.2+0.7
5d
-1.7+0.3-1.9-0.8-0.9
1w
+0.5+1.1-0.6-1.3+1.8
15d
-2.5+4.9-7.4+1.6-4.2
1m
-1.8+5.3-7.1-0.1-1.7
2m
-1.4+6.9-8.3-4.2+2.8
3m
+1.9+11.9-10.0+0.8+1.1
UpDownMarket · Nifty Microcap 250Sector · Healthcare Service Provider peers, median of 24Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Krsnaa Diagnostics reported standalone revenue of INR 6,909.47 million for FY2026, up 1.4% from INR 6,816.95 million in FY2025. Profit after tax grew 24% to INR 1,026.75 million from INR 828.08 million. On consolidated basis, revenue rose 7.8% to INR 7,727.74 million and PAT increased 30.7% to INR 1,014.31 million. The company issued debentures worth INR 4,173.59 million, significantly increasing non-current borrowings from INR 185.04 million to INR 4,371.44 million. Operating cash flow improved to INR 1,341.10 million from INR 893.79 million. An income tax demand of INR 626.90 million was raised against the company for multiple assessment years, which the company is contesting. The board recommended a final dividend of INR 2 per share.

Likely market impact

Strong PAT growth above 25% is positive for shareholders, but the sharp increase in debt and ongoing tax disputes create some risk concerns. The company generated robust operating cash flows demonstrating operational strength.